Lipman Matthew J MD - 45239 Cincinnati, OH

Business Name: Lipman Matthew J MD
Categorized In: Doctors
Address: 6779 Colerain Avenue, Cincinnati, OH 45239
Phone Number: (513) 741-1313
Contact Person: Matthew Lipman
Website Address: midwesteyecenter.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Western Hills Family Dentistry - Cincinnati, OH 45239
Beerman Stephen P MD - Cincinnati, OH 45239
Heis Rissover & Whitten Inc - Cincinnati, OH 45239
Fisher Christian MD - Cincinnati, OH 45239
Sikorski John P MD - Cincinnati, OH 45239
Bartish Lawrence MD - Cincinnati, OH 45239
Pierce Charles MD - Cincinnati, OH 45239
Dillard Charles O MD - Cincinnati, OH 45239
Gilliam Jeremy MD - Cincinnati, OH 45239
Gaines Juanita MD - Cincinnati, OH 45239
Chung Eugene S MD - Cincinnati, OH 45239
Groesbeck Med & Pain Con Cente - Cincinnati, OH 45239
Mercy Medical Assoc - Cincinnati, OH 45239
Wonnell Dirk M MD - Cincinnati, OH 45239
Sanitato James J MD - Cincinnati, OH 45239
Hobart Julie MD - Cincinnati, OH 45239
Cataract Inst of Cincinnati - Cincinnati, OH 45239
West Side Adult Pediatrics - Cincinnati, OH 45239
Family Practice Center - Cincinnati, OH 45239
Salem Foad Dr - Cincinnati, OH 45239

Lipman Matthew J MD provides professional Doctors from its single location at the coordinates 39.2091,-84.58385.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 6779 Colerain Avenue, Cincinnati, Ohio 45239 or contacted through representative Matthew Lipman at (513) 741-1313.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Lipman Matthew J MD through its company website at midwesteyecenter.com. Engage with this business on its social media platforms through on Twitter and on Facebook.